Chemo-induced biology of PD-L1 and in vivo combination immune therapy for ovarian cancer

被引：0
|
作者：
Grabosch, Shannon
Zeng, Feitianzhi
Zhang, Lixin
Ma, Tianzhou
Tseng, George
Edwards, Robert P.
Vlad, Anda M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3208
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3208
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1
    Chardin, Laure
    Leary, Alexandra
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] Therapeutic implications of the tumor microenvironment in ovarian cancer patients receiving PD-1/PD-L1 therapy
    Wang, Yusha
    Zhang, Lei
    Bai, Yun
    Wang, Li
    Ma, Xuelei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [33] In vivo efficacy of intraperitoneal anti-PD-L1 therapy in ovarian cancer
    Grabosch, Shannon
    Mony, Jyothi T.
    Zhang, Lixin
    Ma, Tianzhou
    Tirodkar, Tejas
    Brozick, Joan
    Tseng, George
    Elishaev, Esther
    Edwards, Robert P.
    Huang, Xin
    Vlad, Anda M.
    CANCER RESEARCH, 2015, 75
  • [34] PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
    Bocanegra, Ana
    Fernandez-Hinojal, Gonzalo
    Zuazo-Ibarra, Miren
    Arasanz, Hugo
    Jesus Garcia-Granda, Maria
    Hernandez, Carlos
    Ibanez, Maria
    Hernandez-Marin, Berta
    Martinez-Aguillo, Maite
    Jose Lecumberri, Maria
    Fernandez de Lascoiti, Angela
    Teijeira, Lucia
    Morilla, Idoia
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07):
  • [35] Prospect of combination of anti-PD-1/PD-L1 therapy and other therapeutics for treatment of lung cancer
    WANG Lu-yao
    YAO Rui-xue
    XU Qian-qian
    LIU Jia
    中国药理学与毒理学杂志, 2019, (10) : 888 - 888
  • [36] Impact of radio(chemo)therapy on expression of immune checkpoint ligands PD-L1 and PD-L2 on murine and human melanoma cells
    Riegel, D.
    Baeumler, M.
    Spiljar, M.
    Rueckert, M.
    Frey, B.
    Fietkau, R.
    Derer, A.
    Gaipl, U. S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S132 - S132
  • [37] Blocking the PD-1/PD-L1 axis for cancer therapy
    Drake, C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S12 - S13
  • [38] Exosomal PD-L1 as an immune-modulator in cancer
    Blelloch, R.
    HUMAN GENE THERAPY, 2018, 29 (12) : A11 - A11
  • [39] PD-L1 and intratumoral immune response in breast cancer
    Wang, Zhi-Qiang
    Milne, Katy
    Derocher, Heather
    Webb, John R.
    Nelson, Brad H.
    Watson, Peter H.
    ONCOTARGET, 2017, 8 (31) : 51641 - 51651
  • [40] Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
    Akinleye, Akintunde
    Rasool, Zoaib
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
12345